Welcome to the international HTA database

Showing [23537 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2019	Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)	[Induction immunosuppressive therapy in patients undergoing heart transplantation]
2019	Belgian Health Care Knowledge Centre (KCE)	Cost-effectiveness analysis of HPV vaccination of boys in Belgium
2019	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Dupilumab (atopic dermatitis in adolescents) - Benefit assessment according to §35a Social Code Book V]
2019	Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)	[Evaluation of the effectiveness and cost effectiveness of cardiac rehabilitation programs]
2019	Belgian Health Care Knowledge Centre (KCE)	The use of statins in the primary prevention of cardiovascular disease: an online tool for shared-decision making
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: smoking cessation strategies]
2019	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Andexanet alfa (acute major bleeding) - Benefit assessment according to §35a Social Code Book V]
2019	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Dapagliflozin (type 2 diabetes mellitus) - Addendum to Commission A19-53]
2019	Belgian Health Care Knowledge Centre (KCE)	Proton beam therapy in adults
2019	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Dapagliflozin/metformin (type 2 diabetes mellitus) - Addendum to Commission A19-52]
2019	Belgian Health Care Knowledge Centre (KCE)	Statins for the primary prevention of cardiovascular events
2019	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Olaparib (breast cancer) - Addendum to Commission A19-57]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: considerations relating to the adoption of the learning health-care system approach, the reflective approach, and audit and feedback in the context of managing chronic diseases and multimorbid states]
2019	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Burosumab (X-linked hypophosphataemia) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V (expiry of the decision)]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards: respiratory multiplex NAAT (8 or more targets)]
2019	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Elotuzumab (multiple myeloma) - Benefit assessment according to §35a Social Code Book V]
2019	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Atezolizumab (NSCLC, combination chemotherapy with paclitaxel) - Benefit assessment according to §35a Social Code Book V]
2019	NIHR Health Technology Assessment programme	Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT
2019	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Atezolizumab (breast cancer) - Benefit assessment according to §35a Social Code Book V]
2019	NIHR Health Technology Assessment programme	Cognitive behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCT
2019	NIHR Health Services and Delivery Research programme	Developing a reporting guideline to improve meta-ethnography in health research: the eMERGe mixed-methods study
2019	NIHR Health Services and Delivery Research programme	Innovation to enhance health in care homes and evaluation of tools for measuring outcomes of care: rapid evidence synthesis
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: use of rifapentine in the treatment of latent tuberculosis infection]
2019	Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale (CIUSSS)	[Identification of psychosocial practices and interventions that support the adaptation and rehabilitation of adults with Prader-Willi Syndrome]
2019	NIHR Health Services and Delivery Research programme	Digital and online symptom checkers and assessment services for urgent care to inform a new digital platform: a systematic review
2019	NIHR Health Services and Delivery Research programme	Improving care for women and girls who have undergone female genital mutilation/cutting: qualitative systematic reviews
2019	NIHR Health Services and Delivery Research programme	Multicomponent hospital-led interventions to reduce hospital stay for older adults following elective surgery: a systematic review
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: use of extracorporeal membrane oxygenation (ECMO) in adults in Quebec]
2019	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Charity and corporate boxing: harm mitigation
2019	Health Information and Quality Authority (HIQA)	Health technology assessment of C-reactive protein point-of-care testing to guide antibiotic prescribing for acute respiratory tract infections in primary care settings
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: use of linear accelerators with on-board magnetic resonance imaging (MRI) for real-time MRI-guided radiation therapy treatments]
2019	Health Information and Quality Authority (HIQA)	Health technology assessment of a PrEP programme for populations at substantial risk of sexual acquisition of HIV
2019	Health Information and Quality Authority (HIQA)	Health technology assessment of transcatheter aortic valve implantation (TAVI) in patients with severe symptomatic aortic stenosis at low and intermediate risk of surgical complications
2019	Canadian Agency for Drugs and Technologies in Health (CADTH)	Tisagenlecleucel for acute lymphoblastic leukemia and diffuse large b-cell lymphoma: clinical report
2019	National Institute for Health and Care Excellence (NICE)	Balloon dilation for chronic eustachian tube dysfunction. NICE interventional procedures guidance 665
2019	Canadian Agency for Drugs and Technologies in Health (CADTH)	Optimal use of minimally invasive glaucoma surgery: a health technology assessment
2019	Canary Health Service	[Cost-effectiveness of mechanical thrombectomy for treatment of ischaemic stroke]
2019	National Institute for Health and Care Excellence (NICE)	Irreversible electroporation for primary liver cancer. NICE interventional procedures guidance 664
2019	Canadian Agency for Drugs and Technologies in Health (CADTH)	Dual antiplatelet therapy following percutaneous coronary intervention: clinical and economic impact of standard versus extended duration
2019	National Institute for Health and Care Excellence (NICE)	Midcarpal hemiarthroplasty for wrist arthritis. NICE interventional procedures guidance 663
2019	National Institute for Health and Care Excellence (NICE)	High-intensity focused ultrasound for glaucoma. NICE interventional procedures guidance 661
2019	Canadian Agency for Drugs and Technologies in Health (CADTH)	Community water fluoridation programs: a health technology assessment - review of dental caries and other health outcomes
2019	National Institute for Health and Care Excellence (NICE)	Bioprosthetic plug insertion for anal fistula. NICE interventional procedures guidance 662
2019	NIHR Health Technology Assessment programme	A contingency management intervention to reduce cannabis use and time to relapse in early psychosis: the CIRCLE RCT
2019	National Institute for Health and Care Excellence (NICE)	Implant insertion for prominent ears. NICE interventional procedures guidance 660
2018	NIHR Health Technology Assessment programme	Behavioural activation versus guided self-help for depression in adults with learning disabilities: the BeatIt RCT
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Immunoglobulin for myasthenia gravis chronic treatment]
2018	Canary Health Service	[SEEKER System for the screening of lysosomal storage diseases]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Guselkumab (plaque psoriasis) - Addendum to Commission A17-60]
2018	NIHR Health Technology Assessment programme	Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: systematic reviews and economic evaluation
2018	Penn Medicine Center for Evidence-based Practice (CEP)	Update: Best practices for central venous catheter removal
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[PET/CT scan for solitary pulmonary nodule and non-small cell lung cancer]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Targeted lung denervation using catheter ablation for chronic obstructive pulmonary disease - Addendum to Commission H16-01]
2018	NIHR Health Technology Assessment programme	Pharmacological and non-pharmacological interventions for non-respiratory sleep disturbance in children with neurodisabilities: a systematic review
2018	Penn Medicine Center for Evidence-based Practice (CEP)	Point-of Care Ultrasound for Acute Respiratory Distress
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[LDL-Apheresis in familial hypercholesterolemia and hypertriglyceridemia]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Non-invasive prenatal testing to determine the risk of autosomal trisomies 13, 18 and 21 in high-risk pregnancies]
2018	NIHR Health Technology Assessment programme	Brain and spinal stimulation therapies for phantom limb pain: a systematic review
2018	Penn Medicine Center for Evidence-based Practice (CEP)	Monitoring of Anticoagulation in Patients on Extracorporeal Membrane Oxygenation
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge on organizational models for intensive care units]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Abemaciclib, palbociclib and ribociclib in breast cancer]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Sonidegib (basal cell carcinoma) - Benefit assessment according to §35a Social Code Book V]
2018	NIHR Health Technology Assessment programme	Assessing prognosis and prediction of treatment response in early rheumatoid arthritis: systematic reviews
2018	Penn Medicine Center for Evidence-based Practice (CEP)	Transjugular Intrahepatic Portosystemic Shunts for Patients with Acute Variceal Bleeding
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards, English version updated in June 2020: requirements relating to the institutions responsible for the operation of acute healthcare facilities designated within the Quebec trauma network]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[T2 mapping for articular cartilage assessment]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Benralizumab (asthma) - Benefit assessment according to §35a Social Code Book V]
2018	NIHR Health Technology Assessment programme	Bariatric surgery, lifestyle interventions and orlistat for severe obesity: the REBALANCE mixed-methods systematic review and economic evaluation
2018	Penn Medicine Center for Evidence-based Practice (CEP)	Update: Anticoagulation Management in Paracentesis and Thoracentesis
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Pyridostigmine with aminopyridines in myasthenia gravis or Lambert-Eaton myasthenic syndrome]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ipilimumab (melanoma) - Benefit assessment according to §35a Social Code Book V]
2018	Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)	Treatment Foster Care Oregon for seriously delinquent adolescents
2018	NIHR Health Technology Assessment programme	Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation
2018	Penn Medicine Center for Evidence-based Practice (CEP)	Home Administration of Intravenous Immunoglobulin
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: best practices for runaway prevention and intervention for youths living in rehabilitation centres for young persons with adjustment problems]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Natalizumab for recurrent-remitting and JC virus seropositive multiple sclerosis]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Letermovir (prophylaxis of cytomegalovirus reactivation and disease) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
2018	NIHR Health Technology Assessment programme	Contrast-enhanced ultrasound and/or colour duplex ultrasound for surveillance after endovascular abdominal aortic aneurysm repair: a systematic review and economic evaluation
2018	Penn Medicine Center for Evidence-based Practice (CEP)	Using Patient Generated Health Data in an Electronic Health Record
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of practice: national and international practices in the organization of rehabilitative care for adults with permanent or temporary motor disabilities]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Abiraterone acetate (prostate cancer) - Addendum to Commission A17-64]
2018	Penn Medicine Center for Evidence-based Practice (CEP)	Management of Post-Biopsy Renal Bleeding
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Motor-driven continuous passive motion (CPM) devices after interventions on the knee and shoulder joint]
2018	Penn Medicine Center for Evidence-based Practice (CEP)	Location of Implanted Ports for Chemotherapy
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Glycerol phenylbutyrate (urea-cycle disorders) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
2018	Penn Medicine Center for Evidence-based Practice (CEP)	Best Practices for Treating Acute/Severe Hyperkalemia in the Hospital Setting
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: living environment quality in long-term care facilities for dependent seniors]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ixekizumab (psoriatic arthritis) - Benefit assessment according to §35a Social Code Book V]
2018	Penn Medicine Center for Evidence-based Practice (CEP)	Guidelines for Electrocardiography on Arrival to the Emergency Department
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of practice: regulation of private congregate living facilities for the elderly]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Fluticasone furoate/umeclidinium/vilanterol (COPD) - Benefit assessment according to §35a Social Code Book V]
2018	Penn Medicine Center for Evidence-based Practice (CEP)	Guidelines for Management of Acute Hydronephrosis
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of practice: ministerial standards of access, quality, continuity, efficiency and effectiveness of the service d’intervention de crise dans le milieu 24/7]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Insulin glargine/lixisenatide (type 2 diabetes mellitus) - Benefit assessment according to §35a Social Code Book V]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Alectinib (non-small-cell lung cancer) - Addendum to Commission A17-67]
2018	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Diagnostic effectiveness and safety of elastography in liver fibrosis]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Support for the development of an S3 guideline on natural childbirth - Evidence reports]
2018	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Analysis of the efficacy and safety of orthodontic-orthopedic maxillary expansion devices as an alternative to adenotonsillectomy and/or pharmacological treatment in the management of sleep apnea-hypopnea syndrome in pediatric patients]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Evolocumab (primary hypercholesterolaemia or mixed dyslipidaemia) - Benefit assessment according to §35a Social Code Book V (new scientific findings)]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Brentuximab vedotin (cutaneous T-cell lymphoma) - Addendum to Commission G18-01]